Inventor
SCHURMANN CLAUDIA
US7 patents
Patents
7 patentsUS10961583B2Mar 30, 2021
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
REGENERON PHARMA9 citations82
US11702700B2Jul 18, 2023
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
REGENERON PHARMA4 citations71
US12577562B2Mar 17, 2026
Treatment of glaucoma with Rho Guanine Nucleotide Exchange factor 12 (ARHGEF12) inhibitors
REGENERON PHARMA0 citations59
US12286677B2Apr 29, 2025
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
REGENERON PHARMA0 citations59
US11512309B2Nov 29, 2022
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
REGENERON PHARMA0 citations59
US11767526B2Sep 26, 2023
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
REGENERON PHARMA0 citations57
US11845989B2Dec 19, 2023
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
REGENERON PHARMA0 citations56